|4Feb 23, 8:13 PM ET

Aklog Lishan 4

4 · PAVmed Inc. · Filed Feb 23, 2022

Insider Transaction Report

Form 4
Period: 2022-02-18
Aklog Lishan
DirectorChairman and CEO
Transactions
  • Award

    Employee stock option (right to buy)

    2022-02-18+200,000200,000 total
    Exercise: $1.59Exp: 2032-02-18Common stock (200,000 underlying)
Footnotes (1)
  • [F1]The option vests in 12 quarterly installments, with first installment vesting March 31, 2022.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES